Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer

Clinical trial NCT00063999 · COMPLETED

Trial details

NCT number: NCT00063999
Sponsor: GOG Foundation
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Recurrent Uterine Corpus Carcinoma Stage IIIA Uterine Corpus Cancer AJCC v7 Stage IIIB Uterine Corpus Cancer AJCC v7 Stage IIIC Uterine Corpus Cancer AJCC v7 Stage IVA Uterine Corpus Cancer AJCC v7 Stage IVB Uterine Corpus Cancer AJCC v7

Start date: 2003-08-25
Primary completion: 2013-06-29
Enrollment: 1381

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.